Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo

DALLAS–(BUSINESS WIRE)–Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, BOLD Capital, and Jazz Ventures, among others. Since launching in September 2021, Colossal has raised $225M in total funding. Colossal will leverage this l

Leave a Reply

Your email address will not be published. Required fields are marked *